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Quantification of the Contribution of Cardiac and Arterial
Remodeling to Hypertension
Patrick Segers, Nikos Stergiopulos, Nico Westerhof
Abstract—The study aim was to quantify the individual and combined contributions of both the arterial system and the
heart to systolic blood pressure in hypertension. We assessed the parameters of a heart–arterial model for normotensive
control subjects and hypertensive patients with left ventricular adaptation patterns classified as normal, concentric
remodeling, concentric hypertrophy, or eccentric hypertrophy. The present simulations show that vascular stiffening
alone increases the pulse pressure without increasing systolic blood pressure. It is only in combination with an increased
peripheral resistance that arterial stiffening leads to systolic hypertension in concentric remodeling and concentric
hypertrophy. The contribution of cardiac pump function to the increase in blood pressure depends on cardiac
remodeling, hypertrophy, or both. In hypertensive patients with a normal left ventricle, the heart is responsible for 55%
of the increase in systolic blood pressure. In concentric remodeling, concentric hypertrophy, and eccentric hypertrophy,
the cardiac contribution to the increase in systolic blood pressure is 21%, 65%, and 108%, respectively. We conclude
that along with arterial changes, cardiac remodeling and hypertrophy contribute to hypertension. (Hypertension.
2000;36:760-765.)
Key Words: hypertrophy n arteries n compliance n models n remodeling
Aortic pressure and flow arise from the interaction betweenthe left ventricle (LV) and the systemic arterial load.
Factors that affect LV pump function are preload (venous filling
pressure or LV end-diastolic volume [LVEDV]) and contractile
properties of the heart muscle (LV contractility). The 2 main
mechanical afterload parameters that determine systolic blood
(SBP) and pulse pressure (PP) are total peripheral resistance (R)
and total arterial compliance (C).1,2 Arterial blood pressure is
thus determined by a limited number of cardiac and arterial
mechanical factors. In hypertension, each of these parameters
may change and thus contribute, to a different degree, to the
elevated blood pressure.
Blood pressure in hypertension, measured in vivo,
reflects the combined effects of alterations in cardiac and
arterial parameters. In this work, we use a mathematical
heart–arterial interaction model1 to unravel and quantify
the specific contribution of arterial and cardiac changes.
Cardiac and arterial model parameters for normotensive
control subjects and for hypertensive patients with differ-
ent LV adaptation patterns were taken directly from the
literature or calculated from data given in the literature.3
The effect of individual changes in arterial and cardiac
properties in hypertension was evaluated, and the relative
contribution of cardiac and arterial remodeling to the
increase in SBP was quantitatively assessed.
Methods
Heart–Arterial Interaction Model
Aortic blood pressure is computed with a heart–arterial interaction
model1 (Figure 1). Heart function is described with a time-varying
elastance model4 and is coupled to a 4-element lumped-parameter
windkessel model that represents the arterial load.5 The systemic
arterial model parameters are total peripheral resistance (R), total
arterial compliance (C), total inertance (L), and aortic characteristic
impedance (Z0). Time-varying elastance is calculated as E(t)5PLV/
(VLV2Vd), where PLV and VLV are LV pressure and volume, respec-
tively.4 Cardiac parameters are the slope (Emax) and intercept (Vd) of
the end-systolic pressure-volume relation,4 the slope of the diastolic
pressure-volume relation (Emin) and venous filling pressure (Pv), heart
rate, and the time to reach maximal elastance (tP).4,6 Emax is a measure
for LV contractility, whereas Emin and Pv determine LV filling.
Cardiac valves are simulated as frictionless, perfectly closing de-
vices, that allow only forward flow.
Estimation of Model Parameters
Values of R for control subjects and hypertensives are taken from a
clinical study by Ganau et al.3 Hypertensives are classified according
to 4 different LV adaptation patterns: normal LV (LV mass index
,111 g/m2 in men and 106 g/m2 in women and relative LV wall
thickness of ,0.44), concentric remodeling (normal LV mass index
but elevated relative LV wall thickness), concentric hypertrophy
(both LV mass index and relative LV wall thickness elevated), or
eccentric hypertrophy (elevated LV mass index but normal relative
LV wall thickness) (for details, see Ganau et al3). Total arterial
compliance is calculated from given pressure and flow data as
follows. Stroke volume (SV) is given, and PP is calculated as the
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difference between SBP and diastolic blood pressure (DBP). The
ratio of SV to PP is a measure of compliance but tends to
overestimate windkessel compliance by a factor of ’1.6 in dogs7; we
therefore estimate C as 0.64 times SV/PP. In control subjects, Z0 is
taken 33 mm Hg z L21 z s2; to calculate values for Z0 in patients, we
make use of the fact that Z0 varies in proportion to 1/=C.9 L is a
parameter that represents the inertia of blood and is related to arterial
dimensions and blood density. We assume L55 mm Hg z L21 z s2 for
control subjects and patients.5
In the approximation of end-systolic aortic pressure with LV SBP,
effective arterial elastance (Ea) is given as SBP/SV.10 For the control
population, Ea51510 mm Hg/L (1.51 mm Hg/mL). In normal sub-
jects, the ratio of Ea and Emax is close to 1.11 We therefore assume
Emax51500 mm Hg/L in the control group. Further, LVEDV values
are computed from given end-diastolic diameters and the minor/
major hemiaxis ratio, with the assumption of an ellipsoidal model.
With SV in each subgroup known, LV end-systolic volume
(LVESV) can then be calculated as LVESV5LVEDV2SV. Emax is
approximated as Emax5SBP/(LVESV2Vd). In solving this equation
for Vd with appropriate values for controls (Emax51500 mm Hg/L,
SBP5124 mm Hg, and LVESV52931023 L), Vd is estimated as
253.731023 L in the control group. With Pv55 mm Hg, Emin is
calculated as Pv/(LVEDV153.7), giving a value of 30 mm Hg/L
(0.030 mm Hg/mL) in the control group.
To the best of our knowledge, there are no data on the variation of
the intercept of the end-systolic pressure-volume relation in the
different cardiac adaptation scenarios. Therefore, we use a constant
Vd for all patient groups. Emax can then be calculated directly from the
data reported by Ganau et al.3 Heart rate (70 bpm) and the timing of
maximal contraction (tP50.32 second) are taken as constant. The
changes in LV volume and wall thickness have a similar effect on
passive (Emin) and active (Emax) properties. We thus assume that Emin
changes in proportion to Emax; Pv then follows from Emin, measured
LVEDV, and Vd. The validity of the heart–arterial model and the
assumptions that lead to the model parameter setting is evaluated by
comparing computed pressure and flow with the reported, measured
values.
Contribution of Arterial and Cardiac Changes to
Blood Pressure in Hypertension
To study the individual contribution of alterations in cardiac prop-
erties, arterial model parameters are given the values assessed for the
control group, whereas cardiac model parameters are given the
appropriate values that we assessed in the hypertensive patients.
Isolated changes in R (or C) are studied in an analogous way, with
control cardiac parameters and control C (or R). The difference
between the control and the newly obtained hemodynamic data
yields the contribution of each individual parameter to SBP, PP, and
SV. We further consider combined changes in R and C to quantify
the overall contribution of arterial changes to SBP.
Results
Estimation of Model Parameters
Hemodynamic data and model parameters for control sub-
jects and hypertensives, taken directly or derived from the
work of Ganau et al,3 are summarized in Table 1. Venous
filling pressure, calculated from measured LVEDV and
estimated Emin, varies between 5.6 (normal LV group) and 7.0
(concentric hypertrophy) mm Hg. Measured PP and SV are
predicted within 3% of data reported in literature3; SBP is
estimated within 5% (5% underestimation in eccentric hyper-
trophy group) (Figure 2). We conclude that the model
predicts the human data well.
TABLE 1. Hemodynamic Data and Arterial and Cardiac Model Parameters in Normotensive
Control Subjects and Hypertensive Patients With Different Cardiac Remodeling Patterns Taken
From the Literature
Normotensive
Subjects
(n5125)
Hypertensive Patients
Normal LV
(n587)
Concentric
Remodeling
(n521)
Concentric
Hypertrophy
(n513)
Eccentric
Hypertrophy
(n544)
Age, y 44613 43611 50610 50615 45611
Heart rate, bpm NC 70613 70610 71610 71610
SBP, mm Hg 124610 145616 153621 170634 157622
DBP, mm Hg 7767 97612 100613 110620 102612
LVEDV, 1023 L* 111 115 92 103 146
SV, 1023 L 82617 80617 67615 79616 97616.2
Wall thickness, 1022 m 0.8460.10 0.960.09 1.160.07 1.360.09 160.09
Relative wall thickness 0.3360.04 0.3660.04 0.4960.03 0.5260.04 0.3860.04
LV mass index, g/m2 75617 85617 9369 144623 136627
NC indicates not communicated.
*Calculated value with data given in the literature.3
Figure 1. In the heart–arterial interaction model, the heart func-
tion is modeled as a time-varying elastance function [E(t)]. The
arterial model is a lumped parameter model that consists of
total compliance (C), total peripheral resistance (R), characteris-
tic impedance of the aorta (Z0), and the inertia of blood in the
systemic arteries (L). The model directly yields aorta pressure.
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Contribution of Arterial and Cardiac Changes to
Blood Pressure in Hypertension
In the group of hypertensives with normal LV, the data in
Table 2 show modest alterations in R (increase), C (decrease),
and LV pump function (Emax and Pv increase). R and cardiac
function both contribute positively to SBP; C has little effect
(Figure 3, top row). The increase in R decreases PP, whereas
the changes in C and pump function increase PP. The increase
in R lowers SV, whereas the increase in pump function
increases SV.
In the concentric remodeling group, R and LV pump
function both increase, whereas C decreases (Table 2). The
only parameter that contributes significantly to the increase in
SBP is R (Figure 3, second row). The decrease in C has the
greatest effect on PP (increase), whereas the increase in R has
the greatest effect on SV (decrease).
In the concentric hypertrophy group, R and LV pump
function have increased, whereas C has decreased (Table 2).
The changes in cardiac function and R both contribute to the
higher SBP (Figure 3, third row). The increase in R results in
a lower PP and SV; the increase in pump function results in
a higher PP and SV. The decrease in C increases PP and
lowers SV.
In the eccentric hypertrophy group, only cardiac preload
parameters change (Table 2). The increase in preload results
in higher SBP, PP, and SV values (Figure 3, bottom row).
The mathematical model simulations indicate that in the
normal LV group, the SBP increment is about equally due to
arterial (46%) and cardiac (54%) remodeling (Figure 4). In
the concentric remodeling group, arterial changes are the
main factors that contribute to blood pressure (82%). In both
the concentric and eccentric hypertrophy groups, cardiac
geometric alterations are the main contributor to SBP and are
responsible for 58% and 108% of the increase in SBP,
respectively. The 108% increase in SBP in eccentric hyper-
trophy is due to the fact that the arterial changes have a small
negative effect (28%) on SBP.
Discussion
The present study is based on data presented in the literature
of measurements in 125 normal and 165 hypertensive sub-
jects who are classified into 4 groups, depending on measured
LV mass and increase in LV wall thickness.3 Quantitative
analysis that is based on a mathematical model indicates that
depending on the specific patient group, the heart contributes
between 18% and 108% to the increase in SBP. In patients
with a normal LV, there are modest alterations in cardiac and
arterial properties. Individually, none of the changes leads to
hypertension, but their combination does. The concentric
remodeling group is the only patient group in whom the high
blood pressure is almost exclusively attributable to arterial
changes (ie, the increase in peripheral resistance). In the
Figure 2. Agreement between measured
and predicted SBP, PP, and SV in control
subjects and in hypertensive patients with
normal LV, concentric remodeling (CR),
concentric hypertrophy (CH), or eccentric
hypertrophy (EH). The simulations are
obtained with the model parameters given
in Table 2.
TABLE 2. Arterial and Cardiac Model Parameters Used for the Simulation of
Hemodynamics in Normotensive Control Subjects and Hypertensive Patients With
Different Cardiac Remodeling Patterns
Normotensive
Subjects
(n5125)
Hypertensive Patients
Normal LV
(n587)
Concentric
Remodeling
(n521)
Concentric
Hypertrophy
(n513)
Eccentric
Hypertrophy
(n544)
Emax, mm Hg/L 1500 1640 1950 2200 1530
Vd, 1023 L 253.7 253.7 253.7 253.7 253.7
Emin, mm Hg/L 30 33 39 44 31
Pv, mm Hg 5.0 5.6 5.7 7.0 6.2
R, mm Hg z L21 z s 1110 1310 1660 1490 1060
C, 1023 L/mm Hg 1.13 1.08 0.81 0.86 1.15
Z0, mm Hg z L21 z s 33 34 39 38 33
L, mm Hg z L21 z s2 5 5 5 5 5
Model parameters were calculated or estimated from the literature.3 See the text for details on the
assessment of model parameters.
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concentric hypertrophy group, arterial changes yield border-
line hypertension only, whereas the heart is the major
contributor to the increase in blood pressure. The high blood
pressure in the eccentric hypertrophy group can be attributed
almost exclusively to the heart. Overall, increased arterial
load (reduced compliance, increased resistance, or both)
results in a lower SV and lower cardiac output when the pump
function of the heart is unchanged. Our simulations show that
the development of hypertension requires an increase in
peripheral resistance or an increased pump function (Emax,
LVEDV) to generate a higher cardiac output12 and elevated
SBP.
Parallel changes in arterial and cardiac structure and
function have been observed.11,13 Roman et al14 studied
carotid artery structure and function in the same 4 left
ventricular phenotypes. They found that although blood
pressure was the same in the concentric and eccentric
hypertrophy groups, carotid artery dimensions, intima-media
thickness, and stiffness were most abnormal in the concentric
hypertrophy group.14 The data used for our simulations show
reduced total arterial compliance in the concentric hypertro-
phy but also the concentric remodeling group (Table 2). SV
was considerably lower in the latter group than in all others,
leading to higher values for peripheral resistance and lower
values for total arterial compliance. Unfortunately, Roman et
al14 did not report SV, limiting a more detailed and direct
comparison of both data sets.
The LV response to hypertension is a complex dynamic
process, with mechanical, molecular, genetic, and biochemi-
cal factors involved.15 In the present study, we do not
speculate on the mechanisms that trigger arterial or cardiac
remodeling. We simply use reported arterial and cardiac
mechanical parameters, measured at a particular moment
during the disease process, to calculate their effect on blood
Figure 3. Effect of isolated changes in compli-
ance (C), resistance (R), or cardiac parameters (H)
on SBP, PP, and SV. Data are shown for the dif-
ferent cardiac remodeling patterns. The open bar
represents data in the control condition; filled bar,
data obtained with changes in the arterial and
cardiac parameters together (ie, with model pa-
rameters from Table 2, A1H).
Figure 4. Contribution of arterial (resistance and compliance)
and cardiac changes to systolic blood in hypertension, accord-
ing to the different cardiac remodeling patterns (normal LV, con-
centric remodeling [CR], concentric hypertrophy [CH], or eccen-
tric hypertrophy [EH]). The hatched bar represents SBP under
control conditions.
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pressure elevation. When possible, we determined mechani-
cal properties directly from the data (R and C); other
parameters were varied in a relative sense, starting from the
parameters in the control group (Emin). There was a good
agreement (Figure 2) between measured and predicted arte-
rial pressure and flow, which supports that the model param-
eter values we used are correct. The only arbitrary parameter
we entered was venous filling pressure in the control group.
As LVEDV was measured, Pv determines the slope of the
diastolic pressure-volume relation in the control group. In the
patients, we assumed that changes in wall thickness and
volume, changing Emax, proportionally affected diastolic stiff-
ness. Together with measured LVEDV, we thus obtained
estimations for the increase in venous filling pressure. Im-
paired diastolic function in LV hypertrophy has been de-
scribed,16,17 and the elevated venous filling pressure in
concentric hypertrophy is well documented in studies on
chronic pressure overload of the heart.18,19
The outcome of the present study, however, does not
depend on the assumptions we made on the diastolic filling
properties of the LV. Our model couples the LV to the arterial
load and is suitable to study LV systolic function. The preload
parameters Emin and Pv are important because they yield
LVEDV, the extent to which the LV is loaded at the onset of
contraction. In the present study, however, we used the actual
measured values for LVEDV; the choice of either Pv or Emin
yields the other parameter through the definition of E(t), but
their value is only indicative. For the same reason, the model
is not suited to study the effects of impaired LV relaxation of
LV filling hemodynamics.
Recently, much attention was paid to the role of vascular
stiffening in hypertension.20,21 Our model predicts that com-
pliance changes alone have a limited effect on SBP, confirm-
ing experimental results in isolated feline heart preparation22
and in the intact mammal.23,24 Randall et al23 concluded that
compliance changes alone do not lead to (isolated systolic)
hypertension. Kelly et al24 found a 47% increase in SBP after
lowering compliance by 60% to 80%, but in their study,
peripheral resistance (117%) and venous filling pressure
(138%) were also increased, with both effects contributing to
the elevation of blood pressure.
The classification of LV adaptation patterns allows a better
characterization of the hypertensive population. It is, how-
ever, still unclear whether it provides a prognostic value in
addition to LV mass.25,26 Our approach, which enables the
quantification of vascular versus heart components to blood
pressure on a per-patient basis, has the potential to lead to a
better prognostic marker for cardiovascular risk.
The present mathematical model study has some inherent
limitations. Both the heart and the arterial tree were simulated
with linear models; thus, nonlinear properties were neglected.
However, with appropriate model parameters, both models
are good mechanical representations of both physiological
systems, incorporating principal features of both.1,5,27 We
compared aortic blood pressure, given by the model, with
measured sphygmomanometer brachial blood pressure. Due
to wave travel and wave reflection, SBP is higher in the
brachial artery than in the aorta.9 Further, we assumed that an
increase in contractility (Emax) proportionally affects passive
diastolic filling properties (Emin). However, given the uncer-
tainties in the assessment of these parameters and the fact that
we studies relative differences between different groups,
these assumptions do not affect the validity of our results. We
also assumed a constant intercept (Vd) of the end-systolic
pressure-volume relation. Especially in eccentric remodeling,
where the LV pressure-volume loop is shifted to the right, this
assumption may not hold. However, there still is a significant
overlap with the pressure-volume loops measured or simu-
lated in the control group. The rightward shift thus is much
smaller than that seen in patients with cardiac failure, with
severely dilated hearts and LVEDV in the range of 200 to
30031023 L,28 where Vd is expected significantly elevated.
In summary, we have shown that vascular stiffening
widens the arterial pulse without increasing SBP. It is only in
combination with an increased resistance that arterial remod-
eling can lead to hypertension. However, the most important
contribution to blood pressure in hypertension comes from
cardiac remodeling and, thus, altered pump function. Depend-
ing on the remodeling pattern, the cardiac contribution is
responsible for 21% to 108% of the increase in SBP in
hypertension.
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